肠易激综合征患者结肠黏膜miR-219a-5p和miR-338-3p下调并与屏障功能及MAPK信号相关
实时PCR验证显示IBS患者miR-219a-5p(P=.026)和miR-338-3p(P=.004)水平降低,且抑制miR-219a-5p可改变屏障功能相关基因并增加肠道上皮细胞通透性,抑制miR-338-3p则影响MAPK信号通路基因。
要点
- IBS患者结肠黏膜miR-219a-5p和miR-338-3p表达下调。
- 抑制miR-219a-5p增加Caco-2细胞通透性并改变屏障功能基因。
- 抑制miR-338-3p影响MAPK信号通路基因表达。
核心结论
- 在IBS患者中鉴定出两种可能影响肠道通透性和内脏痛觉的microRNA(miR-219a-5p和miR-338-3p)表达改变,可能通过神经元和MAPK信号影响屏障功能与内脏高敏感,并可能成为IBS治疗靶点。
研究设计与样本
- 采用nCounter阵列评估活检标本相关miRNA水平,以错误发现率(FDR)<10%为显著。
- 用实时聚合酶链反应(PCR)验证差异表达基因;在转染miRNA抑制剂或对照抑制剂的Caco-2肠上皮细胞上进行跨上皮电阻(TEER)和葡聚糖通量测定评估屏障功能;用蛋白质印迹确认屏障功能相关基因的蛋白表达。
主要发现
- 在检测的247个miRNA中,有4个在IBS与健康对照间差异表达(FDR<10%)。
- 实时PCR验证提示IBS患者miR-219a-5p(P=.026)和miR-338-3p(P=.004)水平降低,IBS-C患者中miR-219a-5p(P=.02)和miR-338-3p(P=.06)与健康对照相比关联最强。
- 抑制miR-219a-5p导致蛋白酶体/屏障功能基因表达改变。
- 功能上,抑制miR-219a-5p使肠上皮细胞通透性增加,表现为TEER降低(25-50%,P<.05)和葡聚糖通量增加(P<.01)。
- 抑制miR-338-3p引起细胞内丝裂原活化蛋白激酶(MAPK)信号通路基因改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Alterations in microRNA (miRNA) and in the intestinal barrier are putative risk factors for irritable bowel syndrome (IBS). We aimed to identify differentially expressed colonic mucosal miRNAs, their targets in IBS compared to healthy controls (HCs), and putative downstream pathways. METHODS: Twenty-nine IBS patients (15 IBS with constipation [IBS-C], 14 IBS with diarrhea [IBS-D]), and 15 age-matched HCs underwent sigmoidoscopy with biopsies. A nCounter array was used to assess biopsy specimen-associated miRNA levels. A false discovery rate (FDR) < 10% was considered significant. Real-time polymerase chain reaction (PCR) was used to validate differentially expressed genes. To assess barrier function, trans-epithelial electrical resistance (TEER) and dextran flux assays were performed on Caco-2 intestinal epithelial cells that were transfected with miRNA-inhibitors or control inhibitors. Protein expression of barrier function associated genes was confirmed using western blots. RESULTS: Four out of 247 miRNAs tested were differentially expressed in IBS compared to HCs (FDR < 10%). Real-time PCR validation suggested decreased levels of miR-219a-5p and miR-338-3p in IBS (P = .026 and P = .004), and IBS-C (P = .02 and P = .06) vs. HCs as the strongest associations. Inhibition of miR-219a-5p resulted in altered expression of proteasome/barrier function genes. Functionally, miR-219a-5p inhibition enhanced the permeability of intestinal epithelial cells as TEER was reduced (25-50%, P < .05) and dextran flux was increased (P < .01). Additionally, inhibition of miR-338-3p in cells caused alterations in the mitogen-activated protein kinase (MAPK) signaling pathway genes. CONCLUSION: Two microRNAs that potentially affect permeability and visceral nociception were identified to be altered in IBS patients. MiR-219a-5p and miR-338-3p potentially alter barrier function and visceral hypersensitivity via neuronal and MAPK signaling and could be therapeutic targets in IBS.
引用
- Mahurkar-Joshi S, Rankin CR, Videlock EJ, et al. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Gastroenterology. 2021. PMID: 33617890. doi:10.1053/j.gastro.2021.02.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。